{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:25Z","timestamp":1786119385258,"version":"build-2736575974"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Supplement 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1111\/j.1524-4725.2009.01345.x","type":"journal-article","created":{"date-parts":[[2009,10,5]],"date-time":"2009-10-05T13:18:54Z","timestamp":1254748734000},"page":"1661-1666","source":"Crossref","is-referenced-by-count":34,"title":["Clinical Experience With Filler Complications"],"prefix":"10.1097","volume":"35","author":[{"given":"SUE ELLEN","family":"COX","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"Suppl 1","key":"R1-12-20210206","first-page":"S92","article-title":"Understanding, avoiding, and managing dermal filler complications.","volume":"34","author":"Cohen","year":"2008","journal-title":"Dermatol Surg"},{"key":"R2-12-20210206","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.PRS.0000127250.35248.56","article-title":"The use of hyaluronidase to reverse the effects of hyaluronic acid filler.","volume":"114","author":"Lambros","year":"2004","journal-title":"Plast Reconstr Surg"},{"key":"R3-12-20210206","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1468-1293.2004.00190.x","article-title":"A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection.","volume":"5","author":"Moyle","year":"2004","journal-title":"HIV Med"},{"key":"R4-12-20210206","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1097\/00002030-200311210-00009","article-title":"Polylactic acid implants (New Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA.","volume":"17","author":"Valantin","year":"2003","journal-title":"AIDS"},{"key":"R6-12-20210206","first-page":"L36","article-title":"Safety and efficacy of intradermal poly-L-lactic acid (Sculptra) injections in patients with HIV-associated facial lipoatrophy.","volume":"9","author":"Mest","year":"2004","journal-title":"Antivir Ther"},{"key":"R7-12-20210206","first-page":"129","article-title":"Cutaneous biofilms: friend or foe?","volume":"15","author":"Mertz","year":"2003","journal-title":"Wounds"},{"key":"R8-12-20210206","first-page":"426","article-title":"Clinical Conference: Management of rare events following dermal fillers-focal necrosis and angry red bumps.","volume":"32","author":"Narins","year":"2006","journal-title":"Dermatol Surg"},{"key":"R9-12-20210206","first-page":"357","article-title":"Successful management of an unusual presentation of impending necrosis following a hyaluronic acid injection embolus and a proposed algorithm for management with hyaluronidase.","volume":"33","author":"Hirsch","year":"2007","journal-title":"Dermatol Surg"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1111\/j.1524-4725.2009.01345.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:07:00Z","timestamp":1786039620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042728-200910002-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":8,"journal-issue":{"issue":"Supplement 2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1524-4725.2009.01345.x","relation":{},"ISSN":["1076-0512"],"issn-type":[{"value":"1076-0512","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}